Suppr超能文献

慢性肾脏病与经导管主动脉瓣置换术住院结局的相关性。

Association of Chronic Kidney Disease With In-Hospital Outcomes of Transcatheter Aortic Valve Replacement.

机构信息

Division of Cardiology, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York.

Department of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota.

出版信息

JACC Cardiovasc Interv. 2017 Oct 23;10(20):2050-2060. doi: 10.1016/j.jcin.2017.07.044.

Abstract

OBJECTIVES

This study sought to determine the association of chronic kidney disease (CKD) with in-hospital outcomes of transcatheter aortic valve replacement (TAVR).

BACKGROUND

CKD is a known independent risk factor for worse outcomes after surgical aortic valve replacement (SAVR). However, data on outcomes of patients with CKD undergoing TAVR are limited, especially in those on chronic dialysis.

METHODS

The authors used data from the 2012 to 2014 National Inpatient Sample database to identify all patients ≥18 years of age who underwent TAVR. International Classification of Diseases-Ninth Revision-Clinical Modification codes were used to identify patients with no CKD, CKD (without chronic dialysis), or end-stage renal disease (ESRD) on long-term dialysis. Multivariable logistic regression models were constructed using generalized estimating equations to examine in-hospital outcomes.

RESULTS

Of 41,025 patients undergoing TAVR from 2012 to 2014, 25,585 (62.4%) had no CKD, 13,750 (33.5%) had CKD, and 1,690 (4.1%) had ESRD. Compared with patients with no CKD, in-hospital mortality was significantly higher in patients with CKD or ESRD (3.8% vs. 4.5% vs. 8.3%; adjusted odds ratio [no CKD as reference]: 1.39 [95% confidence interval: 1.24 to 1.55] for CKD and 2.58 [95% confidence interval: 2.09 to 3.13] for ESRD). Patients with CKD or ESRD had a higher incidence of major adverse cardiovascular events (composite of death, myocardial infarction, or stroke), net adverse cardiovascular events (composite of major adverse cardiovascular events, major bleeding, or vascular complications), and pacemaker implantation compared with patients without CKD. Acute kidney injury (AKI) and AKI requiring dialysis were associated with several-fold higher risk-adjusted in-hospital mortality in patients in the no CKD and CKD groups. Moreover, the incidence of AKI and AKI requiring dialysis did not decline during the study period.

CONCLUSIONS

Patients with CKD or ESRD have worse in-hospital outcomes after TAVR. AKI is associated with higher in-hospital mortality in patients undergoing TAVR and the incidence of AKI has not declined over the years.

摘要

目的

本研究旨在探讨慢性肾脏病(CKD)与经导管主动脉瓣置换术(TAVR)住院结局的相关性。

背景

CKD 是外科主动脉瓣置换术(SAVR)后预后较差的独立危险因素。然而,CKD 患者行 TAVR 后结局的数据有限,特别是在接受慢性透析的患者中。

方法

作者利用 2012 年至 2014 年国家住院患者样本数据库的数据,确定所有接受 TAVR 的年龄≥18 岁的患者。采用国际疾病分类第九版临床修正版(ICD-9-CM)代码识别无 CKD、无慢性透析的 CKD(CKD)或长期透析的终末期肾病(ESRD)患者。使用广义估计方程构建多变量逻辑回归模型,以检查住院期间的结局。

结果

在 2012 年至 2014 年间接受 TAVR 的 41025 例患者中,25585 例(62.4%)无 CKD,13750 例(33.5%)有 CKD,1690 例(4.1%)有 ESRD。与无 CKD 的患者相比,CKD 或 ESRD 患者的院内死亡率显著更高(3.8%比 4.5%比 8.3%;无 CKD 作为参考的调整优势比[OR]:1.39[95%置信区间:1.24 至 1.55]为 CKD,2.58[95%置信区间:2.09 至 3.13]为 ESRD)。与无 CKD 的患者相比,CKD 或 ESRD 患者主要不良心血管事件(死亡、心肌梗死或卒中的复合终点)、净不良心血管事件(主要不良心血管事件、大出血或血管并发症的复合终点)和起搏器植入的发生率更高。与无 CKD 组患者相比,急性肾损伤(AKI)和需要透析的 AKI 与风险调整后的院内死亡率呈数倍相关。此外,在研究期间,AKI 和需要透析的 AKI 的发生率并未下降。

结论

CKD 或 ESRD 患者行 TAVR 后院内结局较差。AKI 与 TAVR 后患者更高的院内死亡率相关,并且 AKI 的发生率多年来并未下降。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验